Chemkart India Limited has announced the appointment of Ms. Shreya Agarwal as Whole-Time Company Secretary and Compliance Officer, effective January 20, 2026. The appointment was approved by the company's Board of Directors during their meeting held on January 20, 2026, based on the recommendation of the Nomination and Remuneration Committee.

Key Appointment Details

Ms. Shreya Agarwal, an Associate Member of the Institute of Company Secretaries of India with membership number ACS-59432, will serve as both Company Secretary and Compliance Officer. She will also be designated as a Whole-Time Key Managerial Personnel under the Companies Act 2013 and SEBI (LODR) Regulations, 2015.

Professional Background

Ms. Agarwal brings extensive experience of more than six years in critical areas including secretarial compliances, company law, and SEBI listing regulations. The company confirmed that she is not disqualified from being appointed as Company Secretary under the relevant acts and regulations, and has provided her consent to act in this capacity.

Key Managerial Personnel Authorization

The board also authorized Key Managerial Personnel for determining materiality of events and information disclosure under Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015:

Board Meeting Details

The board meeting commenced at 5:00 PM IST and concluded at 5:30 PM IST on January 20, 2026. The decisions were made in compliance with Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, ensuring proper disclosure requirements are met.

Regulatory Compliance

The appointment aligns with the company's commitment to maintaining robust corporate governance standards. Ms. Agarwal's role will be crucial in ensuring compliance with various regulatory requirements and maintaining effective communication with stock exchanges regarding material events and information disclosures.

Chemkart India Limited has filed its related party transaction (RPT) disclosure with BSE Limited for the half year ended September 30, 2025, while also paying a penalty of ₹11,800.00 for alleged regulatory non-compliance.

Regulatory Compliance and Penalty Payment

The company submitted the RPT disclosure under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Chemkart India listed its equity shares on the BSE SME Exchange on July 14, 2025, making the RPT disclosure provisions applicable from that date.

Under Regulation 15(2)(b), SME listed entities have six months from the applicability date to ensure compliance with RPT disclosure requirements. Despite this statutory timeline being available, BSE levied a penalty based on SEBI Master Circular dated November 11, 2024.

Related Party Transaction Overview

The company disclosed comprehensive RPT details for both standalone and consolidated financial statements. The transactions primarily involve subsidiaries, directors, and promoters across various categories including loans, remuneration, and business operations.

Standalone Financial Transactions

The standalone RPT disclosure reveals total transaction value of ₹777.42 lakhs during the reporting period. Key transactions include:

Consolidated Financial Transactions

The consolidated RPT disclosure shows total transaction value of ₹671.66 lakhs. Major components include remuneration to directors and promoters, IPO expense reimbursements, and loans to key management personnel.

Key Related Parties

The disclosed transactions involve several related parties:

• Easy Raw Material Pvt. Ltd. (Subsidiary): Investment, loans, rent income, and interest transactions
• Vinstar Biotech Pvt. Ltd. (Subsidiary): Rent income, interest received, and loan transactions
• Moksha Lifecare Pvt. Ltd.: Sale of goods and services
• Directors and Promoters: Parul Shalish Mehta, Ankit Shalish Mehta, and Shalish Vindora Mehta for remuneration, loans, and reimbursements

Audit Committee Approval

All disclosed transactions received audit committee approval on March 7, 2025, with approved limits ranging from ₹18.00 lakhs to ₹5.00 crores depending on the transaction type and counterparty relationship.

The company emphasized that it was not in actual non-compliance with SEBI regulations, as the statutory timeline for compliance remained available under the applicable provisions. However, to avoid any regulatory observations, the company proactively paid the levied penalty.